People

Governance Verdict at a Glance

Relisted on NYSE March 2026 after UK primary listing as Ashtead Group plc. Inherits a mature board, a CEO with 30 years inside, and a ~$5m total-pay package heavily share-linked. Biggest governance tension: 37% shareholder dissent on the 2024 remuneration policy when RSUs were added. Pay-for-performance discipline is in place; US-style top-up grants on top of a 700%-of-salary PSU did not land cleanly with UK long-only holders.

The People Running This Company

Brendan Horgan (CEO). Joined Sunbelt in 1996, ran the US business from 2011, became Group CEO May 2019. Holds 727,401 SUNB shares post-relisting — at 30 April 2025 this was 1,952% of base salary versus a required 850%, which is the most important alignment fact in this file. Single-shareholder owner-operator type without owner equity — has built a stake the hard way through 30 years of grants and retention.

Alex Pease (CFO). Appointed 1 March 2025 after ten months as CFO Designate. Previously CFO of WestRock through its 2024 merger with Smurfit Kappa; three prior public-company CFO roles plus a decade at McKinsey. Deliberately not appointed to the Board so as to match US practice — accountability runs through the CEO, not directly to shareholders, which is a structural step backward from UK norms.

Paul Walker (Chair). Sixteen years as CEO of Sage Group, currently chair of RELX plc. On the Sunbelt board since 2018, chair since September 2018. The single most experienced public-company chair on the bench and the most credible counterweight to Horgan.

Kyle Horgan (EVP, Specialty). Same surname as the CEO. Holds 91,960 SUNB shares — a larger stake than every non-executive director and most C-suite officers other than the CEO. The proxy does not disclose any family relationship in the read sections, but the surname coincidence on an EVP-level officer with this level of equity is the single most under-disclosed governance item in the file.

What They Get Paid

Pay is heavily variable and visibly responsive. FY25 single-figure pay fell 29% on lower PSU vesting (40.6% vs 93.4% prior cycle) as relative TSR slipped to FTSE 100 fourth quartile. Salary +3.5% vs 4% for the wider workforce — discipline real, not cosmetic. 60:1 CEO-to-median ratio is moderate for a US-listed industrial of this scale (S&P 500 median ~200:1); 119:1 UK-employee ratio is typical FTSE-100.

NED fees are within UK norms and step up with committee chair / SID supplements rather than via stock — appropriate for independence but it does mean non-execs have negligible economic skin in the game.

Are They Aligned?

Ownership map

No founding family, no promoter block. Top two institutions (Dodge & Cox 11%, BlackRock 6%) reported pre-relisting on the UK register; both are long-only / passive — neither is activist. Insider stake is small in absolute terms (well under 1%) but heavy on a salary-multiple basis, which is the right way to read it for a large-cap that has never been founder-owned.

Insider activity — post-relisting Form 4s

Every Form 4 filed since the 2 March 2026 NYSE relisting is an initial ownership disclosure as Ashtead shares converted to SUNB. There are no open-market purchases or sales in the dataset. Insider trading behavior is therefore unknowable until a normal post-listing trading cycle has run; the cleaner read of alignment is salary-multiple shareholding rather than buy/sell flow.

Dilution and capital return

Capital allocation has shifted decisively toward shareholders: total returns up 52% year-on-year, buybacks 4.5x larger. FY25 repurchases of 6.1m shares (1.3% of issued capital) more than offset PSU/RSU grants of roughly 135k shares to the CEO — net share count is shrinking, not diluting. Dilution signal: buying back, not diluting.

Related-party / governance frictions

The proxy does not flag traditional related-party transactions. The two items worth tracking:

1. Kyle Horgan, EVP Specialty — same surname as CEO, 91,960 shares. No disclosure of relationship in the read sections of the FY25 annual report. US proxy filings post-relisting should resolve this.
2. Alex Pease excluded from the Board — by design, to align with US norms ahead of the NYSE listing. Defensible, but it removes a direct line from the CFO to shareholders.

Skin-in-the-game score

Board Quality

Eight of nine directors independent under the UK Code. Tenure heavy on paper — four NEDs in the 6–9 year band at FY25 — but Riches and Fratto step off at September 2025 AGM, replaced by Cesarone and Singleton. Net: healthier tenure mix, two more US-anchored directors ahead of relisting, but Remco loses its chair (Riches) at exactly the wrong moment given the 37% policy dissent.

Real strengths: Walker (RELX) and Twite (IMI) bring sitting FTSE-100 CEO experience. Cockburn (ex-Serco/Aggreko CFO) is genuinely qualified to chair Audit. Two independent committee chairs.

Real gaps:

• No deep US capital-markets veteran on the board today — Cockburn and Riches are UK-flavoured. Cesarone and Singleton may close this but they are unproven on this board.
• Lucinda Riches' replacement as Remco chair has not been announced — succession is mid-flight.
• Audit Committee meeting attendance was 100% and audit work clean, but PwC has been engaged only since September 2023 and FY25 non-audit fees ran at 53% of audit fees (US-listing prep). Watch for normalization.

The Verdict

Strongest positives

• CEO holds 1,952% of salary in stock; pay falls in lockstep with TSR (FY25 single figure down 29%, 2022 PSU at 40.6%).
• $352m of FY25 buybacks dwarfs annual LTI dilution — net share count is shrinking.
• Independent chair with sitting RELX experience; SID is a former FTSE-100 CFO.
• Succession executed cleanly: Pratt retired with disclosed terms, Pease landed via Korn Ferry search, two new NEDs (Cesarone, Singleton) added pre-relisting.

Real concerns

• 36.8% against the 2024 Remuneration Policy and 37.5% against the LTIP amendment — material dissent driven by the 150% RSU top-up on top of a 700% PSU.
• Kyle Horgan (EVP Specialty) — same surname as CEO, 91,960 shares — undisclosed familial relationship in the proxy as read. Material under US disclosure norms.
• CFO not appointed as Board director, by design — defensible but removes a direct accountability line.
• PwC tenure short (since Sep 2023) and non-audit fees elevated at 53% of audit fees during US-listing prep — will need to fall sharply post-listing.
• TSR fourth-quartile in FY25 yet maximum LTI opportunity rose to 850% of salary — pay opportunity expanding while relative performance is contracting.

The single thing most likely to move the grade

• Upgrade to A-: clean US proxy that (a) discloses the Kyle Horgan relationship, (b) lands a fresh credible Remco chair, and (c) puts non-audit fees back below 25% of audit fees within two years.
• Downgrade to B-: any disclosed related-party transaction involving Kyle Horgan that has not previously been on the record, or a repeat policy-vote miss at the first US AGM.